scispace - formally typeset
M

Mitsuru Futakuchi

Researcher at Nagasaki University

Publications -  122
Citations -  3809

Mitsuru Futakuchi is an academic researcher from Nagasaki University. The author has contributed to research in topics: Bone metastasis & Metastasis. The author has an hindex of 32, co-authored 113 publications receiving 3473 citations. Previous affiliations of Mitsuru Futakuchi include Nagoya City University & University of Nebraska–Lincoln.

Papers
More filters
Journal Article

The prostate: A target for carcinogenicity of 2-amino-1 -methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods

TL;DR: Prostate tissues obtained from rats given a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), at a dose of 400 ppm in the diet for 52 weeks were histopathologically evaluated and found to contain prostate carcinomas.
Journal ArticleDOI

Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice

TL;DR: Findings were in favor of the widely proposed mode of action of fiber carcinogenesis, that is, frustrated phagocytosis where the mesotheliomagenic microenvironment on the peritoneal surface is neither qualitatively altered by the density of the fibers per area nor by the formation of granulomas against agglomerates.
Journal ArticleDOI

Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[a]anthracene

TL;DR: Results indicate that antioxidants, and GTC in particular, inhibit rat mammary gland carcinogenesis after DMBA initiation, and the average size of palpable mammary tumors was significantly smaller in the catechol, phytic acid and catechins groups.
Journal ArticleDOI

Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone Interface

TL;DR: It is hypothesized that tumor-stromal interaction alters gene expression in malignant tumor cells and stromal cells creating a unique expression signature that promotes osteolytic breast cancer bone metastasis and that inhibition of such interactions can be developed as targeted therapeutics.